Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2018
At a glance
- Drugs Trabectedin (Primary) ; Carboplatin; Doxorubicin liposomal; Gemcitabine; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms COMPASS
- 22 Mar 2018 Status changed from active, no longer recruiting to recruiting.
- 05 Dec 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 02 Jun 2017 New trial record